Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue  

 

April 1, 2015 – (Organovo) – Organovo Holdings, Inc. (NYSE MKT: ONVO), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, presented data on the company's in vitro three-dimensional kidney tissue at the 2015 Experimental Biology conference in Boston, Massachusetts.

 

 

Posted on 1-Apr-15 by Berry, Cassie
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: